Evidence map›Paper›PMID 42340157›Full record

ArticleJournal of magnetic resonance imaging : JMRI2026

Performance of Free-Running Cardiac and Respiratory Motion-Resolved Whole-Heart 5D MRI in Congenital Heart Disease Patients Using a Gadolinium Enhanced Fast-Interrupted Steady-State Sequence.

Christopher W Roy, Eva Vogeli, Alissia Megalo, Fabienne Dirbach, Jessica A M Bastiaansen, Jérôme Yerly, Marco Mueller, David Rodrigues, Jean-Baptiste Ledoux, Juerg Schwitter and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Christopher W RoyDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-3111-8840
Eva VogeliService of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Alissia MegaloService of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Fabienne DirbachService of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Jessica A M BastiaansenDepartment of Diagnostic, Interventional and Pediatric Radiology (DIPR), Inselspital, Bern University Hospital, Switzerland.
Jérôme YerlyDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-4347-8613
Marco MuellerDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
David RodriguesDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Jean-Baptiste LedouxDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-0447-5073
Juerg SchwitterService of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-9966-6149
Milan PršaDivision of Pediatric Cardiology, Mother-Woman-Child Department, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-9483-7957
Estelle TenischDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-0994-3964
Tobias RutzService of Cardiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0001-5899-291X
Matthias StuberDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID https://orcid.org/0000-0001-9843-2028

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 10003134Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 201292Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_215604Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 320030_173129Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PZ00P3_202140Wellcome Trust 201292
6 · The paper itself

Abstract

backgroundThe performance of 5D imaging in CHD has been previously demonstrated using ferumoxytol rather than gadolinium. PURPOSE: To evaluate the performance of gadolinium enhanced 5D MRI relative to 2D and 3D MRI in CHD patients. STUDY TYPE: Retrospective. SUBJECTS: 45 consecutive CHD patients referred for clinically indicated MRI who underwent 2D, 3D, and 5D MRI. FIELD STRENGTH/SEQUENCE: 2D bSSFP CINE, 3D bSSFP, and 5D FISS at 1.5 T. ASSESSMENT: Scan time (2D, 3D, and 5D), left and right ventricular (LV, RV) end diastolic and end systolic volumes (LVEDV, RVEDV, LVESV, and RVESV, respectively), ejection fraction (LVEF, RVEF) for 2D versus 5D, and image quality on a 4-point Likert scale (3D vs. 5D). STATISTICAL TESTS: Paired comparisons were made using a paired t-test or Wilcoxon signed rank test. Agreement between measurements was evaluated with Bland-Altman analysis including the bias and 95% limits of agreement.

resultsScan time for 5D (6:18 [0]) was significantly shorter than 2D (7:16 [4:39]) and 3D (6:55 [1:30]) MRI. 5D measurements were strongly correlated with 2D measurements of LVEDV (R DATA

conclusionGadolinium-enhanced 5D MRI may provide an efficient and simplified acquisition for CHD patients, with multiple quantitative parameters from 5D being not significantly different from those from reference standard 2D and 3D MRI. EVIDENCE LEVEL: 4 STAGE OF TECHNICAL EFFICACY: 1.

Indexed as

GadoliniumHeartHeart Defects, CongenitalMagnetic Resonance ImagingAdolescentAdultChildContrast MediaFemaleHumansImage EnhancementImage Interpretation, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance Imaging, CineMaleMiddle AgedContrast MediaGadoliniumcardiac functioncongenital heart diseasecoronary magnetic resonance angiographyfree‐runningwhole‐heart

Identifiers

PMID42340157
PMCPMC13578529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.